
    
      This study is designed to evaluate if the FDC tablet of 5 mg saxagliptin/500 mg metformin
      extended release (manufactured in Mt Vernon, Indiana) is bioequivalent to the coadministered
      5 mg saxagliptin and 500 mg metformin XR tablet (manufactured in Evansville, Indiana)
    
  